Answers are grounded in this paper and cite their sources.
Techniques have recently beome available to isolate and grow mesenchymal progenitors and to manipulate their growth under defined in vitro culture conditions. As a result mesenchymal stem cells can be rapidly expanded to numbers that are required for clinical application. This has allowed the clinical testing of culture-expanded MSCs in the context of hematopoietic stem cell transplantation. In this paper we discuss the role of MSCs in hematopoietic engraftment after transplantation.
No takes yet. Share an insight, caveat, or question.
Fibbe et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: